The Impact of a Colonoscopy Monitoring Program on Endoscopists' Performance

August 28, 2024 updated by: Su Jin Chung, Seoul National University Hospital

The goal of this clinical trial is to learn if colonoscopy monitoring program works to adenoma detection rate in endoscopists. It will also learn about the impact on sessile serrated lesion detection rate, adenomas per colonoscopy, sessile serrated lesions per colonoscopy, advanced adenoma detection rate. The main questions it aims to answer are:

Does colonoscopy monitoring program effect on adenoma detection rate in endoscopists?

Participants will:

Receive result of colonoscopy monitoring program or not every 3 months for 1 year

Study Overview

Status

Not yet recruiting

Study Type

Interventional

Enrollment (Estimated)

16

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Endoscopists with at least 1 year of colonoscopy experience

Exclusion Criteria:

  • Endoscopists with less than 1 year of colonoscopy experience

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Feedback group
The feedback group will be notified of the colonoscopy performances.
Adenoma detection rate feedback from colonoscopy monitoring programs
No Intervention: Control group
The control group will not be notified of the colonoscopy performances.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
adenoma detection rate
Time Frame: 1 year
the percentage of patients with at least one histologically proven adenoma
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
sessile serrated lesion detection rate
Time Frame: 1 year
the percentage of patients with at least one histologically proven sessile serrated lesion
1 year
adenomas per colonoscopy
Time Frame: 1 year
the number of detected adenomas divided by the total number of screening colonoscopies
1 year
sessile serrated lesions per colonoscopy
Time Frame: 1 year
the number of detected sessile serrated lesions divided by the total number of screening colonoscopies
1 year
advanced adenoma detection rate
Time Frame: 1 year
the percentage of patients with at least one histologically proven advanced adenoma
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 1, 2024

Primary Completion (Estimated)

September 1, 2025

Study Completion (Estimated)

September 1, 2025

Study Registration Dates

First Submitted

August 27, 2024

First Submitted That Met QC Criteria

August 28, 2024

First Posted (Actual)

August 29, 2024

Study Record Updates

Last Update Posted (Actual)

August 29, 2024

Last Update Submitted That Met QC Criteria

August 28, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2406-162-1549

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe